{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:25:10Z","timestamp":1793474710535,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10505-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:25:24Z","timestamp":1782199524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A large-scale human plasma metabolite atlas from over 380,000 participants"],"prefix":"10.1038","volume":"9","author":[{"given":"Zhirong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4094-0478","authenticated-orcid":false,"given":"Yating","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-2809","authenticated-orcid":false,"given":"Lina","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-8929","authenticated-orcid":false,"given":"Yanan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4113-8092","authenticated-orcid":false,"given":"Xinyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"10505_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","volume":"85","author":"M Mamas","year":"2011","unstructured":"Mamas, M., Dunn, W. B., Neyses, L. & Goodacre, R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch. Toxicol. 85, 5\u201317 (2011).","journal-title":"Arch. Toxicol."},{"key":"10505_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","volume":"27","author":"OD Howes","year":"2022","unstructured":"Howes, O. D., Thase, M. E. & Pillinger, T. Treatment resistance in psychiatry: state of the art and new directions. Mol. Psychiatry 27, 58\u201372 (2022).","journal-title":"Mol. Psychiatry"},{"key":"10505_CR3","doi-asserted-by":"publisher","unstructured":"National Research Council Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease (National Academies Press, 2011) https:\/\/doi.org\/10.17226\/13284.","DOI":"10.17226\/13284"},{"key":"10505_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1013713905833","volume":"48","author":"O Fiehn","year":"2002","unstructured":"Fiehn, O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155\u2013171 (2002).","journal-title":"Plant Mol. Biol."},{"key":"10505_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","volume":"71","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma. Gut. 71, 1203\u20131213 (2022).","journal-title":"Gut"},{"key":"10505_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mas.21548","volume":"38","author":"M Jacob","year":"2019","unstructured":"Jacob, M., Lopata, A. L., Dasouki, M. & Abdel Rahman, A. M. Metabolomics toward personalized medicine. Mass Spectrom. Rev. 38, 221\u2013238 (2019).","journal-title":"Mass Spectrom. Rev."},{"key":"10505_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58129-2","volume":"16","author":"X Yin","year":"2025","unstructured":"Yin, X. et al. Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints. Nat. Commun. 16, 3039 (2025).","journal-title":"Nat. Commun."},{"key":"10505_CR8","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.2174\/1568026617666170707120034","volume":"17","author":"L Puchades-Carrasco","year":"2017","unstructured":"Puchades-Carrasco, L. & Pineda-Lucena, A. Metabolomics applications in precision medicine: an oncological perspective. Curr. Top. Med. Chem. 17, 2740\u20132751 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"10505_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","volume":"25","author":"CB Newgard","year":"2017","unstructured":"Newgard, C. B. Metabolomics and metabolic diseases: where do we stand? Cell Metab. 25, 43\u201356 (2017).","journal-title":"Cell Metab."},{"key":"10505_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2013.11.001","volume":"146","author":"ME Dumas","year":"2014","unstructured":"Dumas, M. E., Kinross, J. & Nicholson, J. K. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 146, 46\u201362 (2014).","journal-title":"Gastroenterology"},{"key":"10505_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan, S. C. et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metab. Clin. Exp. 60, 404\u2013413 (2011).","journal-title":"Metab. Clin. Exp."},{"key":"10505_CR12","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.cell.2024.06.033","volume":"187","author":"H Christofk","year":"2024","unstructured":"Christofk, H. et al. Metabolic heterogeneity in humans. Cell 187, 3821\u20133823 (2024).","journal-title":"Cell"},{"key":"10505_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103551","volume":"71","author":"JT Bjerrum","year":"2021","unstructured":"Bjerrum, J. T., Wang, Y. L., Seidelin, J. B. & Nielsen, O. H. IBD metabonomics predicts phenotype, disease course, and treatment response. eBioMedicine 71, 103551 (2021).","journal-title":"eBioMedicine"},{"key":"10505_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70208","volume":"24","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Association between plasma metabolomic profile and machine learning-based brain age. Aging cell 24, e70208 (2025).","journal-title":"Aging cell"},{"key":"10505_CR15","doi-asserted-by":"publisher","unstructured":"Ko, A. M., Tu, H. P. & Ko, Y. C. Systematic review of the role of alpha-protein kinase 1 in cancer and cancer-related inflammatory diseases. Cancers 14, https:\/\/doi.org\/10.3390\/cancers14184390 (2022).","DOI":"10.3390\/cancers14184390"},{"key":"10505_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1274-5","volume":"20","author":"JA Singh","year":"2019","unstructured":"Singh, J. A. & Cleveland, J. D. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 20, 93 (2019).","journal-title":"BMC Nephrol."},{"key":"10505_CR17","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2337\/dc14-3082","volume":"38","author":"JM Fern\u00e1ndez-Real","year":"2015","unstructured":"Fern\u00e1ndez-Real, J. M., McClain, D. & Manco, M. Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes. Diab. Care 38, 2169\u20132176 (2015).","journal-title":"Diab. Care"},{"key":"10505_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52310-9","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank. Nat. Commun. 15, 8081 (2024).","journal-title":"Nat. Commun."},{"key":"10505_CR19","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","volume":"100","author":"G Nickenig","year":"1999","unstructured":"Nickenig, G. et al. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 100, 2131\u20132134 (1999).","journal-title":"Circulation"},{"key":"10505_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.5551\/jat.62789","volume":"29","author":"T Hirano","year":"2022","unstructured":"Hirano, T. et al. Metabolic properties of lowdensity lipoprotein (LDL) triglycerides in patients with type 2 diabetes, comparison with small dense LDL-cholesterol. J. Atheroscler. Thromb. 29, 762\u2013774 (2022).","journal-title":"J. Atheroscler. Thromb."},{"key":"10505_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"AL Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si, A. L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56\u201368 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"10505_CR22","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1073\/pnas.0802208105","volume":"105","author":"D-S Lee","year":"2008","unstructured":"Lee, D.-S. et al. The implications of human metabolic network topology for disease comorbidity. Proc. Natl. Acad. Sci. USA 105, 9880\u20139885 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10505_CR23","doi-asserted-by":"publisher","first-page":"1392622","DOI":"10.3389\/fgene.2024.1392622","volume":"15","author":"M Bagheri","year":"2024","unstructured":"Bagheri, M. et al. Genotype-based \u201cvirtual\u201d metabolomics in a clinical biobank identifies novel metabolite-disease associations. Front. Genet. 15, 1392622 (2024).","journal-title":"Front. Genet."},{"key":"10505_CR24","doi-asserted-by":"publisher","first-page":"e1004801","DOI":"10.1371\/journal.pgen.1004801","volume":"10","author":"A Ganna","year":"2014","unstructured":"Ganna, A. et al. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet. 10, e1004801 (2014).","journal-title":"PLoS Genet."},{"key":"10505_CR25","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m, B. N., Pedersen, K. M., Wulff, A. B. & Nordestgaard, B. G. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur. Heart J. 44, 1432\u20131445 (2023).","journal-title":"Eur. Heart J."},{"key":"10505_CR26","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.1093\/oncolo\/oyae075","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma. Oncologist 29, e1120\u2013e1131 (2024).","journal-title":"Oncologist"},{"key":"10505_CR27","doi-asserted-by":"publisher","first-page":"e2017703","DOI":"10.1001\/jamanetworkopen.2020.17703","volume":"3","author":"BT Crabb","year":"2020","unstructured":"Crabb, B. T. et al. Comparison of International Classification of Diseases and Related Health Problems, tenth revision codes with electronic medical records among patients with symptoms of coronavirus disease 2019. JAMA Netw. Open 3, e2017703 (2020).","journal-title":"JAMA Netw. Open"},{"key":"10505_CR28","doi-asserted-by":"publisher","first-page":"eaaw3538","DOI":"10.1126\/sciadv.aaw3538","volume":"5","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Genotype-by-environment interactions inferred from genetic effects on phenotypic variability in the UK Biobank. Sci. Adv. 5, eaaw3538 (2019).","journal-title":"Sci. Adv."},{"key":"10505_CR29","unstructured":"Gao, P. et al. A theory of multineuronal dimensionality, dynamics and measurement. Preprint at bioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/214262v2 (2017)."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10505-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:49:23Z","timestamp":1791964163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10505"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10505-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study. The protocols for the UK Biobank were informed of consent obtained from all participants.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1344"}}